137 related articles for article (PubMed ID: 6688679)
1. Prognostic significance of large mediastinal involvement in Hodgkin's disease.
Mazza P; Lauria F; Sciascia R; Emiliani E; Fiacchini M; Baccarani M; Frezza G; Dominici G; Cantore M; Faedi M
Scand J Haematol; 1983 Oct; 31(4):315-21. PubMed ID: 6688679
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-Roussy.
Cosset JM; Henry-Amar M; Carde P; Clarke D; Le Bourgeois JP; Tubiana M
Hematol Oncol; 1984; 2(1):33-43. PubMed ID: 6376317
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy.
Behar RA; Horning SJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):771-6. PubMed ID: 7683016
[TBL] [Abstract][Full Text] [Related]
4. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
5. Bulky mediastinal Hodgkin's disease management and prognosis.
Liew KH; Easton D; Horwich A; Barrett A; Peckham MJ
Hematol Oncol; 1984; 2(1):45-59. PubMed ID: 6547402
[TBL] [Abstract][Full Text] [Related]
6. Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
Grigoraki V; Lilienthal F; Touboul E; Gabarre J; Binet JL; Merle-Béral H
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):437-45. PubMed ID: 8414965
[TBL] [Abstract][Full Text] [Related]
7. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal Hodgkin's disease. Significance of mediastinal involvement in early stage Hodgkin's disease.
Mauch P; Hellman S
Hematol Oncol; 1984; 2(1):69-72. PubMed ID: 6547403
[No Abstract] [Full Text] [Related]
9. Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Fuller LM; Hagemeister FB
Recent Results Cancer Res; 1989; 117():197-204. PubMed ID: 2602645
[No Abstract] [Full Text] [Related]
10. Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
Specht L; Nissen NI
Scand J Haematol; 1986 Apr; 36(4):367-75. PubMed ID: 3754976
[TBL] [Abstract][Full Text] [Related]
11. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
12. Combined modality (ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement.
Anselmo AP; Bove M; Cartoni C; Damico C; Maurizi Enrici R; Falchetto Osti M; Biagini C
Haematologica; 1992; 77(2):177-9. PubMed ID: 1383107
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
[TBL] [Abstract][Full Text] [Related]
14. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Longo DL; Russo A; Duffey PL; Hubbard SM; Glatstein E; Hill JB; Jaffe ES; Young RC; DeVita VT
J Clin Oncol; 1991 Feb; 9(2):227-35. PubMed ID: 1988570
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
Baĭsogolov GD; Afanasova NV; Shakhtarina SV
Med Radiol (Mosk); 1990 May; 35(5):10-3. PubMed ID: 2342405
[No Abstract] [Full Text] [Related]
17. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Hodgson DC; Tsang RW; Pintilie M; Sun A; Wells W; Crump M; Gospodarowicz MK
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1374-81. PubMed ID: 14630276
[TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Ferrant A; Hamoir V; Binon J; Michaux JL; Sokal G
Cancer; 1985 Jan; 55(2):317-22. PubMed ID: 2578082
[TBL] [Abstract][Full Text] [Related]
19. Residual mediastinal mass after treatment of Hodgkin's disease: a decision analysis.
Djulbegovic B; Hendler FJ; Hamm J; Hadley T; Woodcock TM
Med Hypotheses; 1992 Jun; 38(2):166-75. PubMed ID: 1528159
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].
Kanaev SV; Kholin AV; Gershanovich ML; Malinin AP; Semenov II
Med Radiol (Mosk); 1988 Jul; 33(7):40-6. PubMed ID: 3398754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
